Clinical Trials Browser

OTHER × Clinical Trials, Phase II as Topic × Thoracic × Clear all

Small Cell Lung Carcinoma

NCT02382406 2023-05-23

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Phase 1/2 Terminated

46 enrolled 24 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

747 enrolled

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

REGOMUNE